Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment

This policy document (A57386) is a billing and coding guidance article that complements the MolDX LCD L36139 for biomarkers in cardiovascular risk assessment. It does not itself specify clinical indications, coverage limits, or frequency caps; users must consult LCD L36139 and MolDX program requirements for specific coverage criteria, exclusions, documentation requirements, coding, and prior authorization rules.

"This article contains billing and coding guidance only and does not itself define clinical indications; refer to MolDX: Biomarkers in Cardiovascular Risk Assessment LCD L36139 for covered clinical ..."

Sign up to see full coverage criteria, indications, and limitations.